Bioventus Inc. (BVS) has a market capitalization of $667.62M and trades at $9.91. The 52-week range is 5.81-9.53.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 29.1, Earnings Per Share (EPS) of $0.34, annual revenue of $568.09M.
The stock has a beta of 0.69, operates in the Healthcare sector.
